INVNAlger Russell Innovation ETF
Seeks investment results that closely correspond to the performance of the Alger Russell Innovation Index.
By Alger · Launched 2025
Annual Cost
0.55%
#2,921 of 5,861 · average
Fund Size
$10M
#4,909 of 5,861 · small
Return (1Y)Goal
+20.9%
Track Record
1 year
#3,984 of 5,861 · young
Performance
Total-return NAV · USDGrowth of $10,000
$11,646+16.5%
Total-return NAV, USD. Net of fund fees, before tax.
What's inside
How Beacon categorizes this fundAsset class
EquityRegion
North americaCap
Multi cap
Strategy
Index tracking
Factor
Quality
Sector
Information technologyFocus
General Innovation
Index tracked
Alger Russell Innovation Index
What it actually holds
By weightConcentration
Top 10 holdings = 21.9% of fund✓ well diversified
Corcept Therapeutics Inc.
2.3%
Okta Inc.
2.3%
Unity Software Inc
2.2%
Pfizer Inc.
2.2%
Cirrus Logic, Inc.
2.2%
Expedia Group Inc
2.2%
Zoom Communications Inc.
2.1%
NetApp Inc.
2.1%
Exelixis, Inc.
2.1%
Docusign Inc
2.1%
Asset allocation
Stocks
99.8%
Cash
0.1%
By sector
Technology
58.8%
Healthcare
20.4%
Consumer Cyclical
8.7%
Communication
8.1%
Financial Services
2.1%
Industrials
1.9%
Risk profile
Last 12 months · Sharpe & Sortino need 3+ yearsVolatility (1Y)
23.5%High
Year-on-year price swings
Max drawdown
-26.0%Moderate
Worst peak-to-trough loss
Sharpe (3Y)
0.61Decent risk-adjusted returns
Sortino (3Y)
1.84Good downside protection
Listing
- Exchange
- NYSE Arca
Full fund details
- Objective
- Seeks investment results that closely correspond to the performance of the Alger Russell Innovation Index.
- Strategy
- Employs a passive indexing approach to replicate the performance of the Alger Russell Innovation Index, investing primarily in U.S. equity securities of innovative companies. The Fund is concentrated in the software industry and health care sector, with a focus on companies developing or benefitting from new technologies.
- Inception date
- January 6, 2025
- Fund family
- Alger
Similar funds
Same asset class, closest by strategy & exposureWhat's next?
You've looked at INVN. Save it to your watchlist to weigh it against other funds, then turn your shortlist into a portfolio.
Data updated on 2026-08-04